Admission of further shares to trading

IMI

10/09/2026 13:32

RNS Number : 2910U
  
IMI PLC
  
10 September 2026
  
 


10 September 2026
IMI PLC
ADMISSION OF FURTHER SHARES TO TRADING
IMI plc (the "Company") announces, in accordance with the Financial Conduct Authority's Prospectus Rules: Admission to Trading on a Regulated Market (PRM) sourcebook 1.6.4R, that the following shares have been admitted to trading on the Main Market of the London Stock Exchange pursuant to their allotment under the Company's Sharesave Scheme (SAYE).




1


Details of the issuer




a)


Name of issuer


IMI plc




b)


Legal entity identifier (LEI) of issuer


2138002W9Q21PF751R30 




2


Details of the transferable securities admitted to trading




a)


Regulated market


London Stock Exchange - Main Market




b)


Name, type and ISIN of the securities


Ordinary Shares of 28 4/7 pence each
ISIN: GB00BGLP8L22 




c)


Number of further securities admitted to trading covered by this notification


36,952




d)


Total number of securities admitted to trading following further issuance


249,425,032
 




e)


Fungibility


Fully fungible with existing ordinary shares




3


Issue and admission details




a)


Date of issuance and admission to trading


Issued on various dates between 21 January 2026 and 26 August 2026. 




b)


Prospectus information


N/A




 
For further information please contact:
Fran Burge
Deputy Company Secretary
0121 717 3700
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ADMLBLFFQKLXBBB